Cingulate, Inc. CING 深 滬
已收盤 04-02 16:00:00 美东时间
6.14
+0.130
+2.16%
華盛通- 最 高6.3599
- 今 開5.82
- 成交量 33.03万股
- 最 低 5.63
- 昨 收 6.01
- 總市值 7139.97万
- 52周最高 11.89
- 市盈率 靜 --
- 換手率 2.84%
- 52周最低 3.20
- 委 比 -44.52%
- 總股本 1162.86万
- 歷史最高 1236.00
- 量 比 0.90
- 振 幅 12.14%
- 歷史最低 2.574
- 每 手 1
- 風險率 1.25%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多美股大行评级 | 瑞穗上调MongoDB至"跑赢大市"，目标价从290美元升至325美元；麦格理下调小鹏评级至"中性" 目标价从24美元降至19美元
今日重点评级关注：HC Wainwright & Co.：维持Perspective Therapeutics"买入"评级，目标价从12美元升至13美元；Litchfield Hills：维持Star Equity Holdings"买入"评级，目标价从21美元升至28美元
03-24 10:07
Roth Capital Maintains Buy on Cingulate, Lowers Price Target to $14
Roth Capital analyst Boobalan Pachaiyappan maintains Cingulate (NASDAQ:CING) with a Buy and lowers the price target from $16 to $14.
03-24 01:26
What's Going On With Cingulate Stock Today?
Cingulate slipped in premarket trading as investors weighed its wider quarterly loss against a fresh patent win and new funding to support its ADHD drug launch plans.
03-20 23:28
12 Health Care Stocks Moving In Friday's Pre-Market Session
Gainers Azitra (AMEX:AZTR) stock moved upwards by 87.3% to $0.33 during Friday...
03-20 20:05
Cingulate shares are trading lower after the company reported worse-than-expected Q4 EPS results.
Cingulate shares are trading lower after the company reported worse-than-expect...
03-19 00:24
Cingulate Q4 EPS $(0.84) Misses $(0.61) Estimate
Cingulate (NASDAQ:CING) reported quarterly losses of $(0.84) per share which missed the analyst consensus estimate of $(0.61) by 37.03 percent. This is a 500 percent decrease over losses of $(0.14) per share from the
03-18 20:47
美股牛股 | Eightco获Bitmine、木头姐巨额注资！稀土概念美国锑业单日大涨逾19%
Eightco单日飙涨34%，获Bitmine、木头姐巨额注资！稀土概念美国锑业大涨逾19%，五角大楼签署9600万美元稀土供应框架>>
03-17 18:53
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Gainers Greenwich LifeSciences (NASDAQ:GLSI) shares rose 48.6% to $33.13 durin...
01-22 20:05
Cingulate CEO Shane Schaffer Reinstated Following Legal Matter; Mr. Roberts To No Longer Serve As Executive Chairman Of The Board But Will Continue To Serve As Chairman
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. As previously disclosed on August 14, 2025, the board of directors
2025-12-15 22:21
美股大行评级 | 潜在涨幅2566.67%！Ascendiant Capital上调GRI Bio目标价至36美元，维持"买入"评级
今日重点评级关注：Ascendiant Capital：维持GRI Bio"买入"评级，目标价从35美元升至36美元；Ascendiant Capital：维持Atossa Therapeutics"买入"评级，目标价从7.75美元升至8美元
2025-12-09 10:32
